301 related articles for article (PubMed ID: 31486296)
1. Plant molecular farming of virus-like nanoparticles as vaccines and reagents.
Rybicki EP
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1587. PubMed ID: 31486296
[TBL] [Abstract][Full Text] [Related]
2. Production of Potyvirus-Derived Nanoparticles Decorated with a Nanobody in Biofactory Plants.
Martí M; Merwaiss F; Butković A; Daròs JA
Front Bioeng Biotechnol; 2022; 10():877363. PubMed ID: 35433643
[TBL] [Abstract][Full Text] [Related]
3. Viral nanoparticles for in vivo tumor imaging.
Wen AM; Lee KL; Yildiz I; Bruckman MA; Shukla S; Steinmetz NF
J Vis Exp; 2012 Nov; (69):e4352. PubMed ID: 23183850
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
5. The Plant Viruses and Molecular Farming: How Beneficial They Might Be for Human and Animal Health?
Zahmanova G; Aljabali AA; Takova K; Toneva V; Tambuwala MM; Andonov AP; Lukov GL; Minkov I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675043
[TBL] [Abstract][Full Text] [Related]
6. Interactions Between Plant Viral Nanoparticles (VNPs) and Blood Plasma Proteins, and Their Impact on the VNP In Vivo Fates.
Pitek AS; Veliz FA; Jameson SA; Steinmetz NF
Methods Mol Biol; 2018; 1776():591-608. PubMed ID: 29869268
[TBL] [Abstract][Full Text] [Related]
7. Transgenic crops for the production of recombinant vaccines and anti-microbial antibodies.
Peters J; Stoger E
Hum Vaccin; 2011 Mar; 7(3):367-74. PubMed ID: 21346415
[TBL] [Abstract][Full Text] [Related]
8. Plant Virus Nanoparticles for Vaccine Applications.
Santoni M; Zampieri R; Avesani L
Curr Protein Pept Sci; 2020; 21(4):344-356. PubMed ID: 32048964
[TBL] [Abstract][Full Text] [Related]
9. Plant-based vaccines: novel and low-cost possible route for Mediterranean innovative vaccination strategies.
Aboul-Ata AA; Vitti A; Nuzzaci M; El-Attar AK; Piazzolla G; Tortorella C; Harandi AM; Olson O; Wright SA; Piazzolla P
Adv Virus Res; 2014; 89():1-37. PubMed ID: 24751193
[TBL] [Abstract][Full Text] [Related]
10. Applications of viral nanoparticles in medicine.
Yildiz I; Shukla S; Steinmetz NF
Curr Opin Biotechnol; 2011 Dec; 22(6):901-8. PubMed ID: 21592772
[TBL] [Abstract][Full Text] [Related]
11. Icosahedral plant viral nanoparticles - bioinspired synthesis of nanomaterials/nanostructures.
Narayanan KB; Han SS
Adv Colloid Interface Sci; 2017 Oct; 248():1-19. PubMed ID: 28916111
[TBL] [Abstract][Full Text] [Related]
12. Meeting report VLPNPV: Session 5: Plant based technology.
Meador LR; Mor TS
Hum Vaccin Immunother; 2014; 10(10):3068-73. PubMed ID: 25581535
[TBL] [Abstract][Full Text] [Related]
13. Viral nanoparticles: Current advances in design and development.
Arul SS; Balakrishnan B; Handanahal SS; Venkataraman S
Biochimie; 2024 Apr; 219():33-50. PubMed ID: 37573018
[TBL] [Abstract][Full Text] [Related]
14. Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants.
Le Mauff F; Mercier G; Chan P; Burel C; Vaudry D; Bardor M; Vézina LP; Couture M; Lerouge P; Landry N
Plant Biotechnol J; 2015 Jun; 13(5):717-25. PubMed ID: 25523794
[TBL] [Abstract][Full Text] [Related]
15. Virus-like particles produced in plants as potential vaccines.
Scotti N; Rybicki EP
Expert Rev Vaccines; 2013 Feb; 12(2):211-24. PubMed ID: 23414411
[TBL] [Abstract][Full Text] [Related]
16. Citrus sudden death-associated virus as a new expression vector for rapid
Matsumura EE; Guo F; Boogers D; van Oevelen D; Vu ST; Falk BW
Biotechnol Rep (Amst); 2022 Sep; 35():e00739. PubMed ID: 35646618
[TBL] [Abstract][Full Text] [Related]
17. In Planta Production of Fluorescent Filamentous Plant Virus-Based Nanoparticles.
Shukla S; Dickmeis C; Fischer R; Commandeur U; Steinmetz NF
Methods Mol Biol; 2018; 1776():61-84. PubMed ID: 29869235
[TBL] [Abstract][Full Text] [Related]
18. Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-Free Hepatitis B Virions.
Ning X; Luckenbaugh L; Liu K; Bruss V; Sureau C; Hu J
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743374
[TBL] [Abstract][Full Text] [Related]
19. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
20. Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.
Hendin HE; Pillet S; Lara AN; Wu CY; Charland N; Landry N; Ward BJ
Vaccine; 2017 May; 35(19):2592-2599. PubMed ID: 28389100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
